Clear Scientific Reports Positive Phase 2 Results for CS-1103, the First Investigational Therapeutic That Removes Fentanyl from the Body
Fentanyl Phase 2 Trial met all endpoints; Phase 3 planned for H1 2027CAMBRIDGE, Mass., Oct. 1, 2026 /PRNewswire/ -- Clear...
The 800-Pound Gorilla in the Room: DEA Now Confirms Marijuana Production Quotas Are Coming